Quantbot Technologies LP Invests $1.44 Million in Charles River Laboratories International, Inc. $CRL

Quantbot Technologies LP recently acquired a new stake of 9,215 shares in Charles River Laboratories International, valued at approximately $1.44 million. Analysts maintain a “Moderate Buy” rating for CRL, with an average price target of $203.57 and recent upgrades from major firms. The company reported better-than-expected quarterly EPS and revenue despite a slight year-over-year revenue decline, and provided a positive FY2026 EPS guidance.